

Sporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing. The investors included Dr. Ronald DePinho, Sporos Director Peter Feinberg and Chief Scientific Officer Dr. Jeno Gyuris.
Source: Press Release
Sporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing.
Sporos Bioventures, a new biotech company, has secured $38.1 million in Series A financing. The investors included Dr. Ronald DePinho, Sporos Director Peter Feinberg and Chief Scientific Officer Dr. Jeno Gyuris.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination